A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801

Paul A. Carpenter, Mukta Arora, Stephanie J. Lee et al.|Haematologica|2018

Cited by 55